Bridge Biotherapeutics, Inc.

South Korea · 34 Employees
Bridge Biotherapeutics Inc., based in the Republic of Korea, US, and China, is a publicly-traded clinical-stage biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs such as ulcerative colitis, fibrotic diseases, and cancers. The company is developing BBT-401, a first-in-class Pellino-1 inhibitor for the treatment of ulcerative colitis, BBT-877, a novel autotaxin inhibitor for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF), and BBT-176, a potent targeted cancer therapy for non-small cell lung cancer (NSCLC) with C797S triple EGFR mutations.

概述

国家 South Korea
成立时间 2015
总部 Suite 903-2, Bldg B, Innovalley, Seongnam, Gyeonggido, KR, 13486
电话号码
网站 http://www.bridgebiorx.com
LinkedIn http://www.linkedin.com/company/bridgebiorx
Twitter https://twitter.com/BridgeBiorx
Facebook https://facebook.com/bridgebiorx/
员工数 34
行业 research,
简介 Bridge Biotherapeutics Inc., based in the Republic of Korea, US, and China, is a publicly-traded clinical-stage biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs such as ulcerative colitis, fibrotic diseases, and cancers. The company is developing BBT-401, a first-in-class Pellino-1 inhibitor for the treatment of ulcerative colitis, BBT-877, a novel autotaxin inhibitor for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF), and BBT-176, a potent targeted cancer therapy for non-small cell lung cancer (NSCLC) with C797S triple EGFR mutations.

技术

Microsoft Office 365

Other

Nginx

Load Balancers

Outlook

Email Providers

常见问题

Bridge Biotherapeutics, Inc. 在哪里?

Bridge Biotherapeutics, Inc. 的总部位于 Suite 903-2, Bldg B, Innovalley, Seongnam, Gyeonggido, KR, 13486

Bridge Biotherapeutics, Inc. 的电话号码是多少?

Bridge Biotherapeutics, Inc. 的电话号码是

Bridge Biotherapeutics, Inc. 的官方网站是什么?

Bridge Biotherapeutics, Inc. 的公司官方网站是 http://www.bridgebiorx.com

Bridge Biotherapeutics, Inc. 是做什么的?

Bridge Biotherapeutics, Inc. 的业务有哪些?

Bridge Biotherapeutics, Inc. 的年收入是多少?

Bridge Biotherapeutics, Inc. 的收入是 6300000美元

Bridge Biotherapeutics, Inc. 有多少员工?

Bridge Biotherapeutics, Inc. 有 34 名员工

Bridge Biotherapeutics, Inc. 属于哪个行业?

Bridge Biotherapeutics, Inc. 从事以下行业: research

Bridge Biotherapeutics, Inc. 使用什么技术?

Bridge Biotherapeutics, Inc. 使用的一些流行技术包括: Microsoft Office 365,Nginx,Outlook

如何联系 Bridge Biotherapeutics, Inc.?

Bridge Biotherapeutics, Inc. 联系信息: 电话号码:, 网站:http://www.bridgebiorx.com, 邮箱:joe***@***.com

Bridge Biotherapeutics, Inc. 的社交媒体链接是什么?

Bridge Biotherapeutics, Inc. 领英:http://www.linkedin.com/company/bridgebiorx,fackbook:https://facebook.com/bridgebiorx/,twitte:https://twitter.com/BridgeBiorx

Bridge Biotherapeutics, Inc. 是一家上市公司吗?

不是

Bridge Biotherapeutics, Inc. 的最后一轮融资是什么时候?

Bridge Biotherapeutics, Inc.在2019-03-01T00:00:00.000+00:00结束了最后一轮融资,金额达27.2M$。

谁投资 Bridge Biotherapeutics, Inc.?

Bridge Biotherapeutics, Inc. 有 1 家投资者,包括 Shinhan Investment Corp, UTC Investment Co., Ltd., Korea Development Bank。

管理层

Joengbin Ahn

Director Of Communications

Jason Kim

Senior VP, Head of Corporate Development

Eun Park

Director, Clinical Trial Leader

员工

Justin Potnick

Principal Scientist, Medicinal Chemistry

Bo-Bae Seo

R&D전략기획

Sang-Yoon Lee

CMO Head of Oncology

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google